KPTI — Karyopharm Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Karyopharm Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	229	278	191	109	63.7
Net Total Accounts Receivable
Net Total Receivables	22.5	47.1	27	30.8	26.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	276	350	234	156	103
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.56	7.38	4.88	6.28	4.65
Long Term Investments
Other Long Term Assets
Total Assets	305	358	240	164	108
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.7	65.9	69.5	92.3	92.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	385	375	377	350	401
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-79.7	-16.7	-136	-186	-293
Total Liabilities & Shareholders' Equity	305	358	240	164	108
Total Common Shares Outstanding